What does “made from kratom” mean on a 7-OH product? The answer starts with the difference between a trace alkaloid in a leaf and a concentrated ingredient in a finished tablet. 7-Hydroxymitragynine occurs in Mitragyna speciosa, but natural leaf material generally contains only a small amount of it.
The plant and its alkaloids
Kratom trees grow in Southeast Asia. Their leaves carry several alkaloids, especially mitragynine. 7-OH is a related compound present at much lower levels. A leaf sample, an extract, and a product labeled with a specified amount of 7-OH are therefore three different things; their compositions should not be treated as interchangeable.
From mitragynine to 7-OH
To obtain commercial quantities, producers can start with mitragynine extracted from kratom and convert some of it through oxidation. Subsequent purification is intended to separate 7-OH from other compounds. The exact composition depends on the material used, the conversion, and the cleanup process. This overview explains the origin of the ingredient without assuming every manufacturer uses identical methods.
Research on retail samples has found evidence of semisynthetic production in many products labeled 7-OH. It has also identified other compounds alongside the advertised ingredient. A package description cannot replace a measurement of the actual batch.
Reading the test results
A batch-specific certificate of analysis should identify the sample and report the measured 7-OH amount. Testing may also look for related alkaloids, residual processing materials, and contaminants. Check that the batch number on the document matches the product. If a seller publishes only a general certificate, it does not establish the contents of every later batch.
Safety and current rules
7-OH interacts with opioid receptors. Concentration changes the exposure compared with ordinary kratom leaf, so “plant-derived” is not a safety assessment. The FDA has warned about concentrated 7-OH products and says kratom compounds are not approved treatments. Laws and product restrictions vary by jurisdiction and may change.
The practical takeaway is to distinguish natural occurrence from the production of a concentrate, and to rely on current, batch-specific evidence when assessing what a product contains.
Sources: analysis of retail 7-OH products and FDA information on kratom.
